Werkgroep Cardiologische centra Nederland

SIGNIFY (Completed)

Study assessInG the morbidity–mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease
Medicine
ivabradine
Population
ASCVD
Phase
III
Starting year
2009

Director of Study

drs. P.R. Nierop (Cardioloog)
Rotterdam, Franciscus Gasthuis

Publications: SIGNIFY

  • SIGNIFY: Discussant reviewESC 2014 - SIGNIFY - ASCVD
  • Ivabradine in patients with stable coronary artery disease without clinical heart failure: The results of SIGNIFYESC 2014 - SIGNIFY - ASCVD

Publications by WCN study

Publications WCN studies by WCN member